Scientists reveal how XBP1s interacts with IL-15 to enhance the survival of natural killer cells

A new study published in Science Immunology points to a promising therapeutic approach for future cancer treatments based on natural killer cells (NK), which are immune cells that bind to tumor cells and destroy them.

Leave A Comment

Your email address will not be published. Required fields are marked *